MEDICAL care, Cost ofMARKOV processesIn patients with metastatic colorectal cancer (mCRC), beginning chemotherapy with FOLFOX or FOLFIRI * is similar in terms of costs and benefits, according to a cost-effectiveness analysis conducted in the US. Researchers employed a Markov decision model using a...
Improved metastasis- and disease-free survival with preoperative sequential short-course radiation therapy and FOLFOX chemotherapy for rectal cancer compared with neoadjuvant long-course chemoradiotherapy: results of a matched pair analysis. Int J Radiat Oncol Biol Phys. 2017;99(2):417-426. doi:...
Conclusion: FOLFOX scheme offered the best option in the chemotherapy of advanced colorectal cancer. 展开 关键词: colorectal cancer chemotherapeutic regimen cost-effectiveness analysis DOI: 10.1016/S0379-4172(06)60071-1 被引量: 2 年份: 2006
CANCER chemotherapyBackground: International guidelines recommend ivosidenib followed by modified FOLFOX (mFOLFOX) for advanced intrahepatic cholangiocarcinoma (ICC) with isocitrate dehydrogenase 1 (IDH1) mutations. Taiwan National Health Insurance covers only fluorouracil/leucovorin (5-FU/...
The Short Course Oncology Therapy (SCOT) study is an international, multicentre, non-inferiority randomised controlled trial assessing the efficacy, toxicity, and cost-effectiveness of 3 months (3 M) versus the usually given 6 months (6 M) of adjuvant chemotherapy in colorectal cancer. METHODS...
for the well state and minor toxicity state greatly influenced the incremental cost-effectiveness ratio of FOLFOX4.CONCLUSION:In term of cost-comparison,XELOX is expected to dominate FOLFOX4 regimes;Therefore,XELOX provides a more cost-effective adjuvant chemotherapy for colon cancer patients in China....
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomis... Complete resection of metastases can result in cure for selected patients with metastatic colorectal cancer. First BEAT evaluated the safety of ...
- 《Annals of Oncology》 被引量: 0发表: 2016年 Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study PURPOSE: To evaluate the efficacy and safety of bevacizumab when added to first-line oxaliplatin-based ...
Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture BACKGROUND Angiogenesis inhibitors(AIs)combination with cytotoxic chemotherapy is a promising treatment for patients with colorectal cancer(CRC).Aflibercep... T Yoshida,K Takahashi,K Shib...
The article reports on the cost effectiveness of FOLFOX, a chemotherapy treatment for colorectal cancer that consists of the drugs 5-fluorouracil and oxaliplatin, for elderly patients with advanced colon cancer, referencing a study led by D.R. Lairson et al, published in the June 12, 2014 ...